HeartWare International, Inc.
(formerly known as HeartWare Limited)
Announcements / Press Releases
Please download the latest "Acrobat Reader" to view the PDF.
| Notice of Special Meeting of Stockholders - Capital Raising (in PDF) | |
| Annual Employee Equity Allocation (in PDF) | |
| Exercise and Cancellation of Options (in PDF) | |
| Options - Exercise & Cancel (in PDF) | |
| Reinstatement to Official Quotation (in PDF) | |
| Half Yearly Report / Accounts and Review Report (in PDF) | |
| Temporary Suspension of Trading (in PDF) | |
| HeartWare International Surpasses 50 Implants in the US (in PDF) | |
| Cleansing Notice for US$60 Million Placement (in PDF) | |
| Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) | |
| HeartWare International, Inc. Closes US$60 Million Financing (in PDF) | |
| ASX Appendix 4D and Half Year Financial Statements (US GAAP) (in PDF) | |
| HeartWare to Present at Canaccord Adams 29th Annual Global Growth Conference (in PDF) | |
| HeartWare International, Inc. Announces US$55 Million Financing (in PDF) | |
| Joint Termination of Proposed Merger (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Equity Grant (in PDF) | |
| Appendix 4C - Quarterly report for entities admitted on the basis of commitments (in PDF) | |
| Results of Annual Meeting (in PDF) | |
| U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare (in PDF) | |
| Trading Halt (in PDF) | |
| Annual Meeting to be Webcast (in PDF) | |
| Appendix 3Y - Change of Director's Interest Notice (in PDF) | |
| Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) | |
| Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) | |
| Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) | |
| Revised Thoratec Merger Documentation (in PDF) | |
| Annual Meeting (in PDF) | |
| HeartWare to Present at Eighth Annual JMP Securities Research Conference (in PDF) | |
| Form 10-Q : Quarterly Financial Statements 31 March 2009 (in PDF) | |
| Thoratec Files Registration Statement (in PDF) | |
| Quarterly Update and Appendix 4C (in PDF) | |
| HeartWare International Clinical Trial Shows 90% Survival at 180 Days (in PDF) | |
| First International Sales of HeartWare® Ventricular Assist System and US Clinical Trial Enrolment Update (in PDF) | |
| Thoratec and HeartWare Receive Request for Additional Information from US. Federal Trade Commission (in PDF) | |
| Appendix 3B (in PDF) | |
| ASX Appendix 4E - Preliminary Final Report for the 12 Months Ended 31 December 2008 (in PDF) | |
| Form 10-K (in PDF) | |
| HeartWare International to List on NASDAQ (in PDF) | |
| Additional Merger Documentation (in PDF) | |
| Thoratec Corporation to Acquire HeartWare for US$282 Million (in PDF) | |
| Request for Trading Halt (in PDF) | |
| First Implants at Northwestern Memorial Hospital, Chicago, IL (in PDF) | |
| Keith Aaronson, M.D. Appointed Co-Principal Investigator of HeartWare Clinical Trial (in PDF) | |
| Quarterly Update and Appendix 4C (in PDF) | |
| HeartWare Receives CE Mark Approval for Miniaturized Heart Pump System (in PDF) | |
| Presentation at J.P. Morgan Healthcare Conference (in PDF) | |
| 2008 Announcements / Press Releases | |
| 2007 Announcements / Press Releases | |
| 2006 Announcements / Press Releases | |
| 2005 Announcements / Press Releases |
| DISCLAIMER: irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website. |